NCT05261724 is a clinical trial of MRI in Diffusion Tensor Imaging, sponsored by George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures.

What drugs are being tested in NCT05261724?

Interventions in NCT05261724: MRI.

What condition does NCT05261724 study?

NCT05261724 studies Diffusion Tensor Imaging, Tractography, MRI.

Is NCT05261724 still recruiting?

NCT05261724 is currently status unknown. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT05261724

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diffusion-tensor Imaging in Brain Tumors Evaluation

Status unknown Last updated 2 March 2022

What this trial tests

trial testing MRI in Diffusion Tensor Imaging in 100 participants. Status unknown.

Timeline

15 February 2021

Primary endpoint
14 March 2021

14 March 2022

Quick facts

Lead sponsor	George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 February 2021
Primary completion	14 March 2021
Estimated completion	14 March 2022
Sites	1 location across Romania

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Diffusion Tensor Imaging — all drugs for Diffusion Tensor Imaging →
Tractography — all drugs for Tractography →
MRI — all drugs for MRI →

Sponsor

George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures

Who can join

18 and older, any sex, with Diffusion Tensor Imaging or Tractography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary and secondary brain tumors are challenging pathologies regarding diagnosis and treatment. MRI is widely used in the imaging evaluation and surgical planning, due to its spatial resolution and ability of tissular characterization. In this study patients with suspected brain tumors, confirmed by routine MRI evaluation (T1, T2, T2\*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation. By analyzing collected data from MRI evaluation and patient records regarding surgical and histopathological data our aim is to investigate derived imaging biomarkers with impact in the surgical planning and rehabilitation of the patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intraoperative glioblastoma surgery-current challenges and clinical trials: An update.
Patel V, Chavda V. · · 2024 · cited 14× · PMID 39371095 · DOI 10.1016/j.cpt.2023.11.006

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Diffusion Tensor Imaging

Currently open trials in the same condition.

NCT07342075 — Registry Study of Cerebral Small Vessel Disease · recruiting
NCT05968976 — Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET · NA · recruiting

Other George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures trials

Trials by the same sponsor.

NCT07178067 — Longitudinal Evaluation of Short-Chain Fatty Acid Profiles During the Natural Disease Course and a Mediterranean Diet In · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05261724 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05261724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing